The Doctors Lounge - Endocrinology and DiabetesThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. Subscribe to this data using MyMedWorm.Subscribe to this data using GoogleReader.Subscribe to this data using Bloglines.Subscribe to this data using MyYahoo.

Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

• Contents
• Discussions

BPA (Bisphenol A), used in packaging, is linked to metabolic disorders.Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Bisphenol A used in plastic packaging for food and beverages, is associated  with risk of metabolic disorders. [JAMA].
Source: The Doctors Lounge - Endocrinology and Diabetes - October 6, 2008 Category: Endocrinology Tags: Endocrinology News Source Type: info

Byetta (Exenatide) - new once-a-week treatment for type 2 diabetesEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
A new once-weekly treatment for type 2 diabetes could replace the more common twice-daily injection. [Lancet].
Source: The Doctors Lounge - Endocrinology and Diabetes - October 4, 2008 Category: Endocrinology Tags: Endocrinology News Source Type: info

Study to analyze link between PCOS and insulin resistanceEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
New project aims to identify a defective point on the insulin signalling pathway in women with PCOS.
Source: The Doctors Lounge - Endocrinology and Diabetes - June 18, 2007 Category: Endocrinology Tags: Endocrinology News Source Type: info

Actos may reduce cardiovascular risks - study saysEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Actos may slow the progression of cardiovascular disease in patients with type 2 diabetes, according to JAMA article.
Source: The Doctors Lounge - Endocrinology and Diabetes - November 14, 2006 Category: Endocrinology Tags: Endocrinology News Source Type: info

Dehydroepiandrosterone (DHEA) found to have no anti-aging effectsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
DHEA is found to have no effect on aging markers in a two-year study that appears in New England Journal of Medicine.
Source: The Doctors Lounge - Endocrinology and Diabetes - October 23, 2006 Category: Endocrinology Tags: Endocrinology News Source Type: info

Five new facts could change our understanding of starvationEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
In an article published in The Lancet, Rainer Gross, PhD, UNICEF's chief of nutrition discusses five facts about world hunger.
Source: The Doctors Lounge - Endocrinology and Diabetes - July 31, 2006 Category: Endocrinology Source Type: info

Heart complications of hyperthyroidism restricted to AFEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Neither hypo- or hyperthyroidism is associated with a higher risk for other cardiovascular problems.
Source: The Doctors Lounge - Endocrinology and Diabetes - July 31, 2006 Category: Endocrinology Source Type: info

ACTOS shows significant benefits for diabeticsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
A study shows that ACTOS reduces the risk of cardiovascular events by an extra 16% on top of standard medication.
Source: The Doctors Lounge - Endocrinology and Diabetes - July 31, 2006 Category: Endocrinology Source Type: info

Canadian study demonstrates new approach to achieving diabetes controlEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
The INSIGHT study demonstrates early addition of insulin glargine therapy safely achieved better glycemic than adding oral agents.
Source: The Doctors Lounge - Endocrinology and Diabetes - July 31, 2006 Category: Endocrinology Source Type: info

Ruboxistaurin (RBX) may reduce risk of vision loss in diabeticsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Phase III trial demonstrates ruboxistaurin (RBX) may reduce the risk of vision loss especially in diabetic macular edema.
Source: The Doctors Lounge - Endocrinology and Diabetes - July 31, 2006 Category: Endocrinology Source Type: info

Five new facts could change our understanding of starvationEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
In an article published in The Lancet, Rainer Gross, PhD, UNICEF's chief of nutrition discusses five facts about world hunger.
Source: The Doctors Lounge - Endocrinology and Diabetes - May 31, 2006 Category: Endocrinology Source Type: info

Heart complications of hyperthyroidism restricted to AFEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Neither hypo- or hyperthyroidism is associated with a higher risk for other cardiovascular problems.
Source: The Doctors Lounge - Endocrinology and Diabetes - May 19, 2006 Category: Endocrinology Source Type: info

ACTOS shows significant benefits for diabeticsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
A study shows that ACTOS reduces the risk of cardiovascular events by an extra 16% on top of standard medication.
Source: The Doctors Lounge - Endocrinology and Diabetes - May 19, 2006 Category: Endocrinology Source Type: info

Canadian study demonstrates new approach to achieving diabetes controlEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
The INSIGHT study demonstrates early addition of insulin glargine therapy safely achieved better glycemic than adding oral agents.
Source: The Doctors Lounge - Endocrinology and Diabetes - May 19, 2006 Category: Endocrinology Source Type: info

Ruboxistaurin (RBX) may reduce risk of vision loss in diabeticsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Phase III trial demonstrates ruboxistaurin (RBX) may reduce the risk of vision loss especially in diabetic macular edema.
Source: The Doctors Lounge - Endocrinology and Diabetes - May 19, 2006 Category: Endocrinology Source Type: info

Thyroglobulin test reveals Thyroid-cancer recurrence earlyEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Thyroglobulin level detection, even when there is no sign of a tumor, was correlated with a recurrence of cancer within three to five years in about 80 percent of patients.
Source: The Doctors Lounge - Endocrinology and Diabetes - May 19, 2006 Category: Endocrinology Source Type: info